We are live on ! Find out more
XBI icon

State Street SPDR S&P Biotech ETF
XBI

761 hedge funds and large institutions have $9.17B invested in State Street SPDR S&P Biotech ETF in 2024 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 254 increasing their positions, 255 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less repeat investments, than reductions

Existing positions increased: 254 | Existing positions reduced: 255

2.15% less ownership

Funds ownership: 130.81% → 128.67% (-2.1%)

2% less funds holding

Funds holding: 780 → 761 (-19)

6% less capital invested

Capital invested by funds: $9.75B → $9.17B (-$577M)

10% less first-time investments, than exits

New positions opened: 88 | Existing positions closed: 98

22% less funds holding in top 10

Funds holding in top 10: 23 → 18 (-5)

46% less call options, than puts

Call options by funds: $1.59B | Put options by funds: $2.95B

Holders
761
Holders Change
-19
Holders Change %
-2.44%
% of All Funds
10.99%
Holding in Top 10
18
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-21.74%
% of All Funds
0.26%
New
88
Increased
254
Reduced
255
Closed
98
Calls
$1.59B
Puts
$2.95B
Net Calls
-$1.36B
Net Calls Change
+$358M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$402M
2
Goldman Sachs
Goldman Sachs
New York
+$186M
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$146M
4
Bank of America
Bank of America
North Carolina
+$120M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$32.5M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$167M
2
Citigroup
Citigroup
New York
-$140M
3
CHP
Castle Hook Partners
New York
-$131M
4
ACA
Avoro Capital Advisors
New York
-$113M
5
Morgan Stanley
Morgan Stanley
New York
-$79.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCM
776
Graham Capital Management
Connecticut
– -$12.4M -131,000 Closed
Caisse de Depot et Placement du Quebec (CDPQ)
777
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
– -$11.9M -125,700 Closed
NAM
778
Nissay Asset Management
Japan
– -$11.8M -124,283 Closed
BGDI
779
BW Gestao de Investimentos
Brazil
– -$10.4M -110,000 Closed
Hudson Bay Capital Management
780
Hudson Bay Capital Management
Connecticut
– -$10.2M -108,000 Closed
FP
781
FFG Partners
Florida
– -$9.04M -95,249 Closed
TF
782
Trek Financial
Arizona
– -$8.61M -90,760 Closed
QC
783
Quadrature Capital
United Kingdom
– -$8.48M -89,384 Closed
PAMP
784
Polar Asset Management Partners
Ontario, Canada
– -$7.07M -74,500 Closed
FSA
785
Financial Sense Advisors
California
– -$6.13M -64,641 Closed
EPA
786
Element Pointe Advisors
Florida
– -$5.96M -62,775 Closed
SOMRS
787
State of Michigan Retirement System
Michigan
– -$4.74M -50,000 Closed
DRS
788
Deane Retirement Strategies
Louisiana
– -$3.97M -41,848 Closed
KWM
789
KFG Wealth Management
Indiana
– -$3.43M -36,136 Closed
CM
790
Churchill Management
California
– -$3.1M -32,625 Closed
BP
791
Ballentine Partners
Massachusetts
– -$2.57M -27,066 Closed
CM
792
Caption Management
Oklahoma
– -$2.24M -25,000 Closed
SCM
793
Stevens Capital Management
Pennsylvania
– -$2.33M -24,596 Closed
QT
794
Quantbot Technologies
New York
– -$2.24M -23,570 Closed
NL
795
NWAM LLC
Washington
– -$1.96M -21,628 Closed
CI
796
CPR Investments
Michigan
– -$2.01M -21,212 Closed
ES
797
Eagle Strategies
New York
– -$1.96M -20,700 Closed
GSC
798
Ground Swell Capital
South Carolina
– -$1.96M -20,658 Closed
FI
799
Finivi Inc
Massachusetts
– -$1.9M -20,028 Closed
CF
800
Centaurus Financial
California
– -$1.89M -19,864 Closed
30 31
32
33 34

XBI Hedge Fund Activity: Q2 2024 in Review

761 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in State Street SPDR S&P Biotech ETF (XBI) for Q2 2024, worth a combined $9.17B — down 5.9% from $9.75B a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of XBI and 88 opened new positions — a net loss of 10 holders — while 255 trimmed existing stakes and 254 added.

The largest buyer was JP Morgan Chase, adding an estimated $402M. The largest seller was Citadel Advisors, cutting an estimated $167M.

  • 761 institutional investors held State Street SPDR S&P Biotech ETF (XBI) as of Q2 2024, down from 780 in Q1 2024.
  • Funds reported $9.17B of State Street SPDR S&P Biotech ETF stock for Q2 2024, down 5.9% quarter-over-quarter.
  • 88 funds opened new State Street SPDR S&P Biotech ETF positions in Q2 2024 and 98 closed out, a net change of -10 holders.
  • The largest State Street SPDR S&P Biotech ETF buyer in Q2 2024 was JP Morgan Chase, an estimated $402M added.
  • The largest State Street SPDR S&P Biotech ETF seller in Q2 2024 was Citadel Advisors, an estimated $167M sold.

Based on aggregated 13F filings for Q2 2024.